Benchmarks settle flat, Nifty ends at 11,300; Bharti Airtel slips over 2%
All that happened in the markets today
8:49 AM
NEWS ALERT :: Aurobindo Pharma gets US FDA nod for low blood pressure drug Midodrine Hydrochloride, reports CNBC TV18
8:48 AM
BROKERAGE VIEW :: Motilal Oswal Financial Services on Tata Power
CMP: Rs 53 | TP: Rs 66 (+25%) | Reco: Upgrade to Buy
>> Tata Power (TPWR)’s results reflect the benefit of asset monetization plans and better WC management as net debt (excl. restricted cash at CESU) declined to INR444b (from INR471b in FY20).
>> Divestment-related measures (part receipt of International Shipping business, Arutmin, and Tata SED) and the infusion of INR26b from promoters would continue to aid debt reduction. As we build-in expectations of normalization in its EPC businesses and some WC by FY22, we view the risk-reward as favorable at current levels. The approval of a tariff hike at Mundra, possible benefits from the merger of CGPL & Tata Power Solar with TPWR, and favorable InvIT valuations provide upsides.
>> Tata Power (TPWR)’s results reflect the benefit of asset monetization plans and better WC management as net debt (excl. restricted cash at CESU) declined to INR444b (from INR471b in FY20).
>> Divestment-related measures (part receipt of International Shipping business, Arutmin, and Tata SED) and the infusion of INR26b from promoters would continue to aid debt reduction. As we build-in expectations of normalization in its EPC businesses and some WC by FY22, we view the risk-reward as favorable at current levels. The approval of a tariff hike at Mundra, possible benefits from the merger of CGPL & Tata Power Solar with TPWR, and favorable InvIT valuations provide upsides.
8:46 AM
BROKERAGE VIEW :: Motilal Oswal Financial Services on Hindalco
CMP: Rs 176 | TP: Rs 233 (+33%) | Reco: Buy
>> Hindalco’s (HNDL) subsidiary Novelis’ 1QFY21 operating results were weak (in-line). EBITDA was down 40% YoY to USD219m on like-to-like basis (excluding Aleris) due to the impact of Covid-19.
>> However, business performance improved substantially with both volumes and margin now inching back to pre-Covid levels. We have raised our FY21/FY22E EBITDA estimates by 4%/6% and reiterate Buy. Note that valuation at 5.3x FY22E EV/EBITDA (~20% discount to 10-year average) does not factor in the expected ~9% CAGR in EBITDA over FY20-22E.
>> Outlook for Novelis is positive due to by resilience in the beverage can business and global recovery in auto demand (a high margin business).
>> Hindalco’s (HNDL) subsidiary Novelis’ 1QFY21 operating results were weak (in-line). EBITDA was down 40% YoY to USD219m on like-to-like basis (excluding Aleris) due to the impact of Covid-19.
>> However, business performance improved substantially with both volumes and margin now inching back to pre-Covid levels. We have raised our FY21/FY22E EBITDA estimates by 4%/6% and reiterate Buy. Note that valuation at 5.3x FY22E EV/EBITDA (~20% discount to 10-year average) does not factor in the expected ~9% CAGR in EBITDA over FY20-22E.
>> Outlook for Novelis is positive due to by resilience in the beverage can business and global recovery in auto demand (a high margin business).
8:43 AM
BROKERAGE VIEW :: Jefferies on Graphite India
Maintains 'Buy'
>> Co's Q1 revenue beat our expectations but EBITDA fell short
>> Covid disruption led to poor offtake, impacting realisations and volume
>> We trim FY21 margin, retain FY22/23 estimates
>> Co's Q1 revenue beat our expectations but EBITDA fell short
>> Covid disruption led to poor offtake, impacting realisations and volume
>> We trim FY21 margin, retain FY22/23 estimates
8:39 AM
BROKERAGE VIEW :: Jefferies on Tata Power
>> Co reported near-zero EBITDA
>> Co has seen severe downturn in Q1 but should see growth sequentially
>> See tailwind from passenger vehicle imports, new emission parts, defence
>> Co has seen severe downturn in Q1 but should see growth sequentially
>> See tailwind from passenger vehicle imports, new emission parts, defence
8:36 AM
BROKERAGE VIEW :: Morgan Stanley on Cummins India
Maintains 'Overweight', Target price: Rs 460
>> Low commodity prices and forex benefit cushioned margins
>> Next 12-18 months remain challenging
>> Low commodity prices and forex benefit cushioned margins
>> Next 12-18 months remain challenging
8:34 AM
Nifty may face resistance in sub-11,350 zone
As per weekly option data, handful of call writing on higher strikes, ranging from 11,300 to 11,500, which shows Nifty would face resistance in the sub-11,350 zone. 11,200 might act as support as maximum put OI stands here. We can witness short-covering move along with addition of fresh position only if Nifty breaches level of 11,350. Therefore, traders should try to create long position, keeping close eye on 11,200. READ MORE
8:26 AM
FII/FPI & DII trading activity on NSE, BSE and MSEI
8:25 AM
Rupee check
Source: Bloomberg
8:22 AM
Oil edges lower after jump on US stocks draw
>> Crude oil prices eased slightly on Thursday but held most of their gains from the previous session after US government data showed a fall in inventories, supporting the view that fuel demand is returning despite the coronavirus pandemic.
>> Brent crude was down 8 cents at $45.35 a barrel, after a gain of around 2% in the previous session. West Texas Intermediate oil was down by 6 cents at $42.61 a barrel after gaining 2.6% on Wednesday
(Source: Reuters)
(Source: Reuters)
8:19 AM
SGX Nifty update
>> At 8:18 am, the index was at 11,322.5 level, up 13.5 points or 0.10 per cent.
8:16 AM
Asian stocks set to track Wall Street's defiant rally
Source: Reuters
8:14 AM
S&P 500 finishes within points of record high close
Source: Reuters
Topics : Coronavirus Markets Ashok Leyland Aurobindo Pharma Hero MotoCorp Eicher Motors BPCL Indiabulls Housing Finance MARKET WRAP
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Aug 13 2020 | 7:28 AM IST